Lv7
3490 积分 2022-09-19 加入
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
3个月前
已完结
Novel strategies exploiting interleukin-12 in cancer immunotherapy
3个月前
已完结
In vivo CAR engineering for immunotherapy
5个月前
已完结
From Concept to Cure: The Evolution of CAR-T Cell Therapy
5个月前
已完结
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
5个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
5个月前
已完结
Antibody–Bottlebrush Conjugates Unlock Diverse Payloads for Targeted Cancer Therapy
6个月前
已完结
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
6个月前
已完结
Antibody–bottlebrush prodrug conjugates for targeted cancer therapy
6个月前
已完结
Engineered Virus‐Like Nanoparticles Enable Multimodal Protein Degradation for Enhanced Tumor Therapy
6个月前
已完结
皖公网安备34019202002308
